Research by the University College, London, has shown that HIV was resistant to the drug TENOFOVIR in 60% of cases in several African countries while developed countries have  only 20 –percent.
Lead author, Dr. Ravi Gupta, is extremely concerned that the work which took four years to complete, started in 2012, compared patients in Africa with HIV patients in Europe.

He opined that poor administration of the drug is largely responsible and a global effort is required to provide better facilities and monitoring in poorer African countries.

No Comments

Leave a Comment